IBD and Colorectal Cancer

Inflammatory bowel disease (IBD) is a chronic condition that causes inflammation in the digestive tract. While IBD can affect daily life through symptoms such as abdominal pain, diarrhea, and fatigue, it may also increase the risk of developing colorectal cancer, particularly in people with long-standing inflammation of the colon.

Understanding this connection is important. With appropriate medical care, regular monitoring, and timely screening, people living with IBD can take important steps to protect their digestive health.

What Is Inflammatory Bowel Disease (IBD)?

IBD is an umbrella term for chronic inflammatory conditions that affect the gastrointestinal tract. The two main types are:

• Ulcerative colitis (UC): Causes inflammation and ulcers in the lining of the colon and rectum.

• Crohn’s disease: Can cause inflammation in different parts of the digestive tract, from the mouth to the anus. When Crohn’s disease affects the colon, it can also increase colorectal cancer risk.

IBD is different from irritable bowel syndrome (IBS). IBS does not cause the chronic intestinal inflammation associated with IBD.

How Does IBD Increase the Risk of Colorectal Cancer?

Colorectal cancer develops when abnormal cells in the colon or rectum grow uncontrollably. In people with IBD affecting the colon, several factors may contribute to an increased risk.

1. Long-term inflammation

Persistent inflammation can damage the cells lining the colon. Over many years, repeated inflammation and tissue repair may contribute to changes in these cells, potentially leading to precancerous changes and cancer.

2. Extensive colon involvement

People whose ulcerative colitis or Crohn’s disease affects a larger portion of the colon may have a higher risk than those with inflammation limited to a small area.

3. Duration of the disease

The risk generally increases with the duration of colonic IBD, especially when inflammation remains active over time. This is why long-term monitoring is an important part of managing the condition.

Important: Having IBD does not mean you will develop colorectal cancer. The level of risk varies depending on your disease, its location, duration, and how well inflammation is controlled.

Who Is at Greater Risk?

Certain factors may increase the likelihood of colorectal cancer in people with IBD:

• Long-standing ulcerative colitis or Crohn’s disease involving the colon.

• Extensive or persistent inflammation of the colon.

• A personal history of precancerous changes, known as dysplasia.

• A family history of colorectal cancer, particularly in a close relative diagnosed at a younger age.

• Primary sclerosing cholangitis (PSC), a chronic disease affecting the bile ducts that is associated with IBD and increased colorectal cancer risk.

People with IBD limited to the small intestine or with ulcerative colitis confined to the rectum generally do not have the same IBD-related colorectal cancer risk as those with more extensive colonic disease. Their screening needs should still be discussed with their healthcare provider.

What Is the Role of Colonoscopy?

Colonoscopy is an important tool for monitoring people with IBD who are at increased risk of colorectal cancer.

Unlike a routine screening colonoscopy, a surveillance colonoscopy is performed specifically to monitor the colon for precancerous changes and early signs of cancer.

During the procedure, a gastroenterologist:

• Examines the lining of the colon and rectum.

• Looks for abnormal areas, polyps, or dysplasia.

• May take small tissue samples (biopsies) for laboratory examination.

• Assesses the extent and activity of inflammation.

Finding abnormal changes early can help doctors recommend appropriate treatment before cancer develops or identify cancer at an earlier stage.

When should surveillance begin?

For many people with IBD involving the colon, an initial surveillance colonoscopy is recommended approximately 8 years after the onset of symptoms. People with PSC and IBD may need surveillance starting at the time PSC is diagnosed.

The timing of follow-up colonoscopies depends on individual risk factors and previous findings. Some people may need examinations annually, while others may have longer intervals. Your gastroenterologist will determine the appropriate schedule.

Can You Reduce Your Risk?

Although you cannot eliminate every risk factor, managing IBD and maintaining regular medical follow-up can help protect your colon.

Keep inflammation under control

Follow your prescribed IBD treatment plan and attend regular appointments. Controlling inflammation is an important part of reducing long-term complications.

Attend recommended colonoscopy appointments

Do not postpone surveillance just because you feel well. Precancerous changes may not cause noticeable symptoms.

Discuss your personal and family history

Tell your gastroenterologist if a close relative has had colorectal cancer or if you have previously been diagnosed with dysplasia or PSC.

Report changes in your symptoms

Contact your healthcare provider if you notice persistent changes in bowel habits, rectal bleeding, unexplained weight loss, or worsening abdominal discomfort. These symptoms do not necessarily mean cancer, but they should be assessed.

Symptoms You Should Never Ignore

Colorectal cancer may not cause symptoms in its early stages. However, seek medical advice if you experience:

• Blood in your stool or rectal bleeding.

• Persistent changes in bowel habits, such as diarrhea or constipation.

• Abdominal pain or cramping that does not improve.

• Unexplained weight loss.

• Ongoing fatigue or weakness, which may be associated with anemia.

These symptoms can also occur with IBD flares and other digestive conditions. Your doctor can determine whether further investigation is needed.

Protect Your Digestive Health with Expert Care

Living with IBD means taking a proactive approach to your digestive health. Although IBD can increase the risk of colorectal cancer, regular surveillance, effective inflammation management, and early evaluation of concerning symptoms can make a meaningful difference.

If you have ulcerative colitis or Crohn’s disease involving the colon, speak with your gastroenterologist about your individual cancer risk and whether you need a surveillance colonoscopy.

At Abu Hammour Gastroenterology Center in Dubai Healthcare City, our team provides expert evaluation and personalized digestive health care, including assessment and monitoring for people living with IBD.

Don't wait for symptoms to appear. Discuss your screening needs with a gastroenterologist.

📍 Abu Hammour Gastroenterology Center – Dubai Healthcare City 📞 04 363 5353

Book your appointment today.

This article is for educational purposes only and does not replace professional medical advice. Screening recommendations should be individualized by your gastroenterologist.